Diabetes

If the Affordable Care Act is repealed, providers of the Diabetes Prevention Program will need to replace the path to Medicare reimbursement that were covered in the law.

Director Tom Frieden, MD, MPH, said the results show that a population health—based approach can save lives and money when there are "rigorous" standards for accountability.

The addition of new a chief medical officer and a new chief commercial officer comes as the digital health provider is poised to scale up delivery of the National Diabetes Prevention Program in Medicare.

The judge's ruling allows 30 days for an appeal but encourages the parties to work out a settlement. The case involves competing, expensive drugs to control cholesterol.

This week in managed care, readers chose the top healthcare news story of 2016, 4 physician groups appealed to Congress to have a replacement for Obamacare ready if it is repealed, and the American College of Physicians released a new guideline on oral medications for type 2 diabetes.

The intervention involves limiting carbohydrates to 40% of calories and having participants maintain muscle mass, so energy levels remain high.

An increasing prevalence of type 2 diabetes and poor glycemic control among youth in the United States has highlighted the need for early detection of prediabetes.

Research on the role of community health workers shows that they can help patients manage their hypertension, in part by addressing barriers to medication adherence.

The American College of Physicians' oral medication guideline for treating type 2 diabetes is the first update since 2012, and it reflects many new medications that have received FDA approval since that time.

As 2016 drew to a close, The American Journal of Managed Care (AJMC)® polled readers on what was, in their opinion, the biggest healthcare story of the year. Runners-up included drug pricing drama, Medicare policy announcements, and more, but the top answer by far was the news story that sent shockwaves throughout the healthcare industry and around the world.

A glimpse at the top 5 articles from The American Journal of Managed Care's® conference coverage that caught reader attention in 2016.

Why a mobile health coaching company sees its move from per member per month to outcomes-based payment as the right thing-for employers and for consumers.

Evaluation of US healthcare data between 1996 and 2013 found that 20 conditions accounted for half of all spending in the United States, with diabetes leading the way.

Important updates of the past year sought to recognize the importance of obesity care and the need to better integrate behavioral health into diabetes care.

The American Journal of Managed Care provides coverage from its live meetings, the ACO & Emerging Healthcare Delivery Coalition, Patient-Centered Oncology Care, and Patient-Centered Diabetes Care.

As 2016 draws to a close, here’s a look at the top 5 news articles that captured reader interest on AJMC.com.

Diabetes and obesity are major public health priorities that are highly associated with environmental factors and correlated with the availability of open space in neighborhoods and communities.

This week, the top managed care stories included CMS announcing more mandatory bundled payment models and a new track in the Medicare Shared Savings Program, the FDA approving a new use for Dexcom's continuous glucose monitor, and a greater emphasis on lifestyle management in the American Diabetes Association's care standards.

There's no shortage of reader interest in Afrezza-the inhaled, meal-time insulin from MannKind-despite reports from Wall Street that the prescription count is climbing slowly.

The study drug targets both the SGLT1 protein, which affects blood glucose absorption in the gastrointestinal tract, and the SGLT2 protein, which affects reabsorption by the kidney.

A study that purported to doubt on the scientific evidence supporting current sugar intake guidelines has been criticized for its funding source: the sugar, food, and beverage industries.

Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016.

The expanded use for Novo Nordisk's new basal insulin comes 15 months after the initial FDA approval.

On the day of the approval, top FDA and CMS officials write in JAMA of the need to share data for better healthcare delivery.

The findings come as CMS targets cardiac procedures in both its hospital readmission reduction program and in a bundled payment model set to take effect July 1, 2017.